Science News for ACC.21

The American Heart Association's Science News from ACC.21 coverage brings you results and insights into selected important scientific trials presented at ACC.21, a virtual conference held May 15-17, 2021. Find at-a-glance data summaries, exclusive interviews, simultaneous publications, and more – all in one place.

Jump to one day's coverage: Saturday  |  Sunday  |  Monday

Quick Reference:
AHA Journals Simultaneous Publications

Saturday's Selected Science

PARADISE-MI

Prospective Arni Versus Ace Inhibitor Trial To Determine Superiority In Reducing Heart Failure Events After Myocardial Infarction
Marc A. Pfeffer, MD, PhD | Distinguished Dzau Professor of Medicine, Harvard Medical School, Brigham and Women’s Hospital, Boston, MA

PARADISE-MI Results

Investigator Marc Pfeffer, MD, PHD summarizes the results of PARADISE-MI.

ADAPTABLE

Aspirin Dosing: A Patient-centric Trial Assessing Benefits And Long-term Effectiveness Trial
Schuyler Jones, MD | Duke University Medical Center, Durham, NC

ADAPTABLE Study Results

Erin Michos, MD, MHS, FAHA interviews Schuyler Jones, MD about the results of ADAPTABLE.

 


Sunday's Selected Science

DARE-19

Effects Of Dapagliflozin On Prevention Of Major Clinical Events And Recovery In Patients With Respiratory Failure Due To COVID-19 - Main Results From The DARE-19 Randomized Trial
Mikhail Kosiborod, MD | Saint Luke's Mid America Heart Institute, Kansas City, MO

DARE-19 Results

Sandeep Das, MD interviews investigator Mikhail Kosiborod, MD about the results of DARE-19.

Monday's Selected Science

CONNECT-HF

Care Optimization Through Patient And Hospital Engagement Clinical Trial For Heart Failure: Primary Results Of The Connect-hf Randomized Clinical Trial
Adam D. DeVore, MD, MHS | Duke Clinical Research Institute, Durham, NC

CONNECT-HF Results

Larry Allen, MD, MHS interviews investigator Adam DeVore, MD, MHS about the results of CONNECT-HF.

HOLIDAY Monitors Study

Acute Alcohol Consumption And Discrete Atrial Fibrillation Events
Gregory M Marcus, MD, MAS | University of California, San Francisco, San Francisco, CA

HOLIDAY Monitors Study Results

Sana M. Al-Khatib, MD, MHS interviews Gregory Marcus, MD, MAS about the results of the HOLIDAY Monitors Study.

Other Late Breaking Science & Simultaneous Publications from ACC.21

Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy (PRADA) Extended Follow-Up of a 2×2 Factorial, Randomized, Placebo-Controlled, Double-Blind Clinical Trial of Candesartan and Metoprolol
Siri Lagethon Heck, et al. | Circulation | May 16, 2021

Late Outcomes of the RAPID-TnT Randomized Controlled Trial: 0/1-Hour High-Sensitivity Troponin T Protocol in Suspected ACS
Kristina Lambrakis, et al. | Circulation | May 16, 2021

Effects of Sacubitril/Valsartan on Serum Lipids in Heart Failure with Preserved Ejection Fraction
Senthil Selvaraj, et al. | JAHA | May 16, 2021

Contemporary National Patterns of Eligibility and Utilization of Novel Cardioprotective Anti‐hyperglycemic agents in Type 2 Diabetes
Arash A Nargesi, et al. | JAHA | May 15, 2021

Temporal Trends, Clinical Characteristics and Outcomes of Emergent Coronary Artery Bypass Grafting for Acute Myocardial Infarction in the United States
Sri Harsha Patlolla, et al. | JAHA | May 15, 2021

Association of Health Insurance Payer Type and Outcomes After Durable Left Ventricular Assist Device Implantation: An Analysis of the STS-INTERMACS Registry
Sameed Ahmed M, et al. | Circulation: Heart Failure | May 15, 2021

Association Between Angiotensin Receptor-Neprilysin Inhibition, Cardiovascular Biomarkers, and Cardiac Remodeling in Heart Failure with Reduced Ejection Fraction
Sean P. Murphy, et al. | Circulation: Heart Failure | May 15, 2021

Social Determinants of Adherence to COVID-19 Risk Mitigation Measures Among Adults with Cardiovascular Disease
Kobina K., et al. | Circulation: Cardiovascular Quality and Outcomes | May 6, 2021

Hospital Variation in 30‐Day Readmissions Following Transcatheter Aortic Valve Replacement
Dhaval Kolte., et al. | JAHA | May 3, 2021